Search

Anna Kathy Aman

Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )

Most Active Art Unit
2914
Art Unit(s)
2914, 2973
Total Applications
3318
Issued Applications
3249
Pending Applications
17
Abandoned Applications
54

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14435465 [patent_doc_number] => 20190175604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-13 [patent_title] => EZH2 INHIBITORS FOR TREATING LYMPHOMA [patent_app_type] => utility [patent_app_number] => 16/181747 [patent_app_country] => US [patent_app_date] => 2018-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12913 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16181747 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/181747
EZH2 INHIBITORS FOR TREATING LYMPHOMA Nov 5, 2018 Abandoned
Array ( [id] => 16420504 [patent_doc_number] => 20200345702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-05 [patent_title] => METHOD FOR TREATING THALASSEMIA [patent_app_type] => utility [patent_app_number] => 16/758986 [patent_app_country] => US [patent_app_date] => 2018-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8685 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758986 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/758986
Method for treating thalassemia Oct 25, 2018 Issued
Array ( [id] => 14833185 [patent_doc_number] => 20190274993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => GLUTAMINASE INHIBITOR THERAPY [patent_app_type] => utility [patent_app_number] => 16/164581 [patent_app_country] => US [patent_app_date] => 2018-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35087 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16164581 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/164581
Glutaminase inhibitor therapy Oct 17, 2018 Issued
Array ( [id] => 16204753 [patent_doc_number] => 20200237743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => CRAC CHANNEL MODULATORS FOR TREATING ESOPHAGEAL CANCER [patent_app_type] => utility [patent_app_number] => 16/756077 [patent_app_country] => US [patent_app_date] => 2018-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9211 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756077 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/756077
CRAC CHANNEL MODULATORS FOR TREATING ESOPHAGEAL CANCER Oct 15, 2018 Abandoned
Array ( [id] => 17923019 [patent_doc_number] => 11466254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-11 [patent_title] => Composition containing, as active ingredient, culture of chicken bone marrow-derived osteochondral progenitor cells for promoting osteogenesis or inducing chondrogenic differentiation [patent_app_type] => utility [patent_app_number] => 16/757335 [patent_app_country] => US [patent_app_date] => 2018-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12000 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757335 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/757335
Composition containing, as active ingredient, culture of chicken bone marrow-derived osteochondral progenitor cells for promoting osteogenesis or inducing chondrogenic differentiation Oct 15, 2018 Issued
Array ( [id] => 16930777 [patent_doc_number] => 20210196666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => Compounds For Inhibiting Secretory Leukocyte Protease Inhibitor (SLPI) [patent_app_type] => utility [patent_app_number] => 16/754912 [patent_app_country] => US [patent_app_date] => 2018-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10198 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754912 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/754912
Compounds for inhibiting secretory leukocyte protease inhibitor (SLPI) Oct 8, 2018 Issued
Array ( [id] => 16341586 [patent_doc_number] => 20200306236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => COMBINATION THERAPIES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/754083 [patent_app_country] => US [patent_app_date] => 2018-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22266 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754083 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/754083
Combination therapies and uses thereof Oct 4, 2018 Issued
Array ( [id] => 14712593 [patent_doc_number] => 20190247360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => Pharmaceutical Composition for Treating Bacterial and Viral infections [patent_app_type] => utility [patent_app_number] => 16/153589 [patent_app_country] => US [patent_app_date] => 2018-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1942 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16153589 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/153589
Pharmaceutical Composition for Treating Bacterial and Viral infections Oct 4, 2018 Abandoned
Array ( [id] => 14403709 [patent_doc_number] => 20190167698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => Methods of Treating Certain Depressive Disorders and Delirium Tremens [patent_app_type] => utility [patent_app_number] => 16/150782 [patent_app_country] => US [patent_app_date] => 2018-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14027 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16150782 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/150782
Methods of treating certain depressive disorders and delirium tremens Oct 2, 2018 Issued
Array ( [id] => 14712521 [patent_doc_number] => 20190247324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => One or a Combination of Phyto-Cannabinoids in the Treatment of Epilepsy [patent_app_type] => utility [patent_app_number] => 16/149983 [patent_app_country] => US [patent_app_date] => 2018-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7087 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16149983 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/149983
One or a Combination of Phyto-Cannabinoids in the Treatment of Epilepsy Oct 1, 2018 Abandoned
Array ( [id] => 13867295 [patent_doc_number] => 20190029988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => EXTENDED DURATION LOCAL ANESTHETIC FORMULATION [patent_app_type] => utility [patent_app_number] => 16/148080 [patent_app_country] => US [patent_app_date] => 2018-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4955 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16148080 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/148080
Extended duration local anesthetic formulation Sep 30, 2018 Issued
Array ( [id] => 16612086 [patent_doc_number] => 20210030739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => COMPOSITIONS AND METHODS OF TREATING CANCER [patent_app_type] => utility [patent_app_number] => 16/649277 [patent_app_country] => US [patent_app_date] => 2018-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20747 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649277 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/649277
Compositions and methods of treating cancer Sep 27, 2018 Issued
Array ( [id] => 16236683 [patent_doc_number] => 20200253917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH [patent_app_type] => utility [patent_app_number] => 16/651835 [patent_app_country] => US [patent_app_date] => 2018-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6817 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651835 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/651835
COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH Sep 27, 2018 Abandoned
Array ( [id] => 17602850 [patent_doc_number] => 11331319 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Combination treatment for neuropsychiatric disorders [patent_app_type] => utility [patent_app_number] => 16/651001 [patent_app_country] => US [patent_app_date] => 2018-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19607 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651001 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/651001
Combination treatment for neuropsychiatric disorders Sep 26, 2018 Issued
Array ( [id] => 18188571 [patent_doc_number] => 11579147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-14 [patent_title] => Use of VNN1 as a biomarker and a therapeutic target in sarcomas [patent_app_type] => utility [patent_app_number] => 16/649860 [patent_app_country] => US [patent_app_date] => 2018-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 11175 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649860 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/649860
Use of VNN1 as a biomarker and a therapeutic target in sarcomas Sep 24, 2018 Issued
Array ( [id] => 14594025 [patent_doc_number] => 10350187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-16 [patent_title] => Methods and composition for suppression of pathogenic bacterial growth, fungal growth, or microbial growth in or on skin [patent_app_type] => utility [patent_app_number] => 16/133793 [patent_app_country] => US [patent_app_date] => 2018-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 5181 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133793 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/133793
Methods and composition for suppression of pathogenic bacterial growth, fungal growth, or microbial growth in or on skin Sep 17, 2018 Issued
Array ( [id] => 15571391 [patent_doc_number] => 10576053 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-03 [patent_title] => Composition containing eicosapentaenoic acid alkyl ester, and method for producing same [patent_app_type] => utility [patent_app_number] => 16/134140 [patent_app_country] => US [patent_app_date] => 2018-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14225 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16134140 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/134140
Composition containing eicosapentaenoic acid alkyl ester, and method for producing same Sep 17, 2018 Issued
Array ( [id] => 14743821 [patent_doc_number] => 20190255084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => DIAGNOSTICS AND METHODS FOR TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSIS AND HEPATIC STEATOHEPATITIS, AND PREVENTION OF COMPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 16/133322 [patent_app_country] => US [patent_app_date] => 2018-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57695 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133322 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/133322
Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereof Sep 16, 2018 Issued
Array ( [id] => 17466695 [patent_doc_number] => 11273152 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-15 [patent_title] => TRPV2 antagonists [patent_app_type] => utility [patent_app_number] => 16/647995 [patent_app_country] => US [patent_app_date] => 2018-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15765 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647995 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/647995
TRPV2 antagonists Sep 13, 2018 Issued
Array ( [id] => 16267263 [patent_doc_number] => 20200268750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => AGENT [patent_app_type] => utility [patent_app_number] => 16/647440 [patent_app_country] => US [patent_app_date] => 2018-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18541 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647440 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/647440
Glycolysis-activating agents for treatment or prevention of disease Sep 12, 2018 Issued
Menu